Importantly, the decreases in bacterial-induced CNS disease severity seen with NK-1R inhibition or deficiency were associated with diminished CNS production of key inflammatory mediators including IL-6 and TNF-α, and the prevention of infection-induced decreases in the level of the anti-inflammatory cytokine IL-10. This evidence concerns the gene TACR1 and infection.